المؤلفون: Helia Robert-Ebadi, Grégoire Le Gal, Marc Philip Righini

المساهمون: Service d'angiologie et d'hémostase (MR), Hôpital Universitaire de Genève, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Calvez, Ghislaine

المصدر: Clinical Interventions in Aging
Clinical Interventions in Aging, Vol. 4 (2009) pp. 165-177
Clin Interv Aging
Clin Interv Aging, 2009, 4, pp.165-77
Clinical Interventions in Aging, Vol Volume 4, Pp 165-177 (2009)
Scopus-Elsevier

مصطلحات موضوعية: Male, medicine.drug_mechanism_of_action, MESH: Factor Xa, Heart Valve Diseases, Review, 030204 cardiovascular system & hematology, MESH: Risk Assessment, Fondaparinux, Hemorrhagic disorder, MESH: Venous Thromboembolism, MESH: Aged, 80 and over, 0302 clinical medicine, Atrial Fibrillation, MESH: Renal Insufficiency, 030212 general & internal medicine, Renal Insufficiency, anticoagulation, MESH: Aged, ddc:616, Aged, 80 and over, hemorrhagic risk, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, valvular heart disease, Atrial fibrillation, General Medicine, Heparin, MESH: Accidental Falls, 3. Good health, MESH: Atrial Fibrillation, thrombin inhibitors, Factor Xa, Female, Risk assessment, medicine.drug, medicine.medical_specialty, Heart Valve Diseases/drug therapy, Factor Xa Inhibitor, venous thromboembolism, MESH: Anticoagulants, elderly patients, Hemorrhagic Disorders, Risk Assessment, 03 medical and health sciences, medicine, Anticoagulants/pharmacokinetics/pharmacology/therapeutic use, Humans, cardiovascular diseases, Intensive care medicine, Aged, MESH: Humans, business.industry, Atrial Fibrillation/drug therapy, Renal Insufficiency/chemically induced, factor Xa inhibitor, RC952-954.6, Anticoagulants, MESH: Heart Valve Diseases, medicine.disease, Venous Thromboembolism/prevention & control, Hemorrhagic Disorders/etiology, MESH: Male, Geriatrics, Accidental Falls, Geriatrics and Gerontology, business, MESH: Female, MESH: Hemorrhagic Disorders, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Discovery and development of direct thrombin inhibitors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee615594e40d6673e44743cce1492d6
http://europepmc.org/articles/PMC2685237

المؤلفون: Flesch, Reinhard

المساهمون: Universität Erlangen

Degree: doctoral -- Friedrich-Alexander Universität, Erlangen -- 1968.